THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE
- 1 May 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 313 (8123) , 954-956
- https://doi.org/10.1016/s0140-6736(79)91725-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidoneLife Sciences, 1978
- HYPOTENSION PRODUCED BY INTRAVENOUS APOMORPHINE IN THE ANAESTHETIZED DOG IS NOT CENTRALLY MEDIATEDBritish Journal of Pharmacology, 1978
- Apomorphine Hydrochloride-Induced Improvement in Huntington's ChoreaArchives of Neurology, 1978
- Pharmacology and Neurochemistry of ApomorphinePublished by Elsevier ,1978
- Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in parkinsonismPsychopharmacology, 1976
- TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1974
- Apomorphine in huntington's chorea: Clinical observations and theoretical considerationsLife Sciences, 1974
- Injected Apomorphine and Orally Administered Levodopa in ParkinsonismArchives of Neurology, 1972
- Similarities between Neurologic Effects of L-Dopa and of ApomorphineNew England Journal of Medicine, 1970
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967